Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Investigating a New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis

NCT03216928 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03216928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03216928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Investigating a New Mode of Action of Anti-TNF, Reverse Signaling, in Rheumatoid Arthritis
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2017
Completion date
March 12, 2020
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis